CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Fuse›
Library
Fuse

Fuse

AI workflow automation for US healthcare providers covering insurance eligibility, claims, and revenue intelligence.

Operating headquarters
London, GB🇬🇧
Founded
2024
Accelerator
Y Combinator logoY CombinatorS24
Loading
Overview
Analysis
Compare
Fundraising
Employees
News
Library

Fuse - Library

fuseinsight.com·Crawled Oct 1, 2026·

Topics

Publication type

Content origin
Row density

Blog

6 pages
  1. Alaska Healthcare Compliance/blog/alaska-healthcare-compliance
  2. Allowed Amount Behavioral Health Anthem Blue Cross California/blog/allowed-amount-behavioral-health-anthem-blue-cross-california
  3. automating-drip-campaigns-ehr-data-roadblocks-workarounds/blog/automating-drip-campaigns-from-ehr-data-common-roadblocks-and-proven-workarounds

    Discover roadblocks when automating drip campaigns from EMR data and proven workarounds to streamline patient engagement for healthcare practices.

  4. Blog/blog

    Discover expert articles on insurance verification, CPT-level benefits, and healthcare automation. AI-powered solutions for providers and billing teams.

About

1 page
  1. About Us/about-us

    Meet the team behind Fuse: healthcare automation specialists dedicated to price transparency, operational efficiency, and empowering clinics.

Homepage

1 page
  1. Homepage/

    Fuse is a complete healthcare automation platform: insurance checks, claims, and the revenue intelligence layer that ties them together for owners, RCM leaders, and CFOs.

Privacy

1 page
  1. Privacy Policy/privacy-policy

    Fuse is committed to protecting your privacy. Discover how we securely handle healthcare data, respect your rights, and comply with HIPAA and SOC 2 Type 2 standards.

Coverage

5 items
  1. Fuse Presents at 2025 MGMA Alaska Conferencefuseinsight.com/blog/fuse-at-2025-mgma-alaska-conference/

    Fuse's co-founders present at the 2025 MGMA Alaska Conference on using CMS machine-readable files to enable price transparency for patients and providers. Their presentation addresses the role of these files in making healthcare prices more transparent to both groups.

    Apr 2025 · Fuse BlogNews article

  2. Fuse Joins Winner's Circle at HIMSS 2025 for Addressing Workforce Shortagesfuseinsight.com/blog/fuse-joins-winners-circle-at-himss-2025/

    Fuse is named to the Winner's Circle at the HIMSS Emerge Innovation Experience 2025. The recognition is for its solution supporting hospitals facing workforce and staffing shortages.

    Mar 2025 · Fuse BlogNews article

  3. Fuse Wins ViVE 2025 Startup Pitch Competition for Price Transparency Innovationfuseinsight.com/blog/fuse-wins-vive-2025-startup-pitch-competition/

    Fuse wins the ViVE 2025 Startup Pitch Competition in Nashville, earning a $25,000 cash prize and recognition for its healthcare price transparency technology.

    Feb 2025 · Fuse BlogNews article

  4. Why We Started Fuse: Fixing US Healthcare's Opacityfuseinsight.com/blog/why-we-started-fuse/

    Fuse co-founder Sho Sugihara describes why the company was started and its mission to make healthcare costs transparent to patients before treatment. Fuse uses AI and automation to pursue that goal.

    Jan 2025 · Fuse BlogNews article